Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-024, a Novel Precision Medicine Product Candidate for Patients with Severe Insulin Resistant Diabetic Nephropathy (DN)
a novel oral formulation targeting down regulation of IgA1 for the treatment of primary IgA Nephropathy (IgAN), has been granted accelerated assessment procedure by the European Medicine Age..查看文章
The global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary IgA nephropathy (IgAN), consists of two parts. The trial met its..查看文章
"Dapagliflozin may be a novel therapeutic option to slow kidney function decline in patients with IgA nephropathy," Hiddo J. L. Heerspink, PhD, said at the International Society of Nephrolog..查看文章
May 13, 2021 (Market Insight Reports) -- Selbyville, Delaware IgA Nephropathy (IgAN) Market research is an intelligence report with meticulous efforts undertaken to study the right and valua..查看文章
nephropathy与发音含义,同义词,反义词,翻译,刑和更多的